journal article·2024-12Open access

PAD4 Inhibitor‐Loaded Layered Double Hydroxide Nanosheets as a Multifunctional Nanoplatform for Photodynamic Therapy‐Mediated Tumor Metastasis Treatment

Rong Chen, Tingting Hu, Yu Lu, Shuqing Yang, Min Zhang, Chaoliang Tan, Ruizheng Liang, Yuji Wang

Small· Volume 20· Issue 50

Abstract

Abstract Photodynamic therapy (PDT) is demonstrated to be effective in inducing antitumor immune responses for tumor metastasis treatment. However, tumor hypoxia, inferior tissue penetration of light, and low singlet oxygen (1O2) quantum yield significantly hamper the efficacy of PDT, thus weakening its immune function. Moreover, PDT‐mediated neutrophil extracellular traps (NETs) formation can further reduce the therapeutic effectiveness. Herein, the use of defect‐rich CoMo‐layered double hydroxide (DR‐CoMo‐LDH) nanosheets as a carrier to load a typical peptidyl arginine deiminase 4 inhibitor, i.e., YW4‐03, to construct a multifunctional nanoagent (403@DR‐LDH) for PDT/immunotherapy, is reported. Specifically, 403@DR‐LDH inherits excellent 1O2 generation activity under 1550 nm laser irradiation and improves the half‐life of YW4‐03. Meanwhile, 403@DR‐LDH plus 1550 nm laser irradiation can stimulate immunogenic cell death to promote the maturation of dendric cells and activation/infiltration of T cells and significantly downregulate H3cit protein expression to inhibit NETs formation, synergistically promoting the antitumor metastasis effect. Taken together, 403@DR‐LDH can kill cancer cells and inhibit tumor growth/metastasis under 1550 nm laser irradiation. Single‐cell analysis indicates that 403@DR‐LDH can regulate the ratio of immune cells and immune‐related proteins to improve the tumor immune microenvironment, showing strong efficacy to inhibit the tumor growth, metastasis, and recurrence.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medicinal Chemistry College of Pharmaceutical Sciences of Capital Medical University Beijing 100069 P. R. China

Department Electrical and Electronic Engineering The University of Hong Kong Pokfulam Road Hong Kong SAR 999077 P. R. China

State Key Laboratory of Chemical Resource Engineering Beijing Advanced Innovation Center for Soft Matter Science and Engineering Beijing University of Chemical Technology Beijing 100029 P. R. China

Department of Nephrology Affiliated Beijing Chaoyang Hospital of Capital Medical University Beijing 100020 P. R. China

Department Electrical Engineering City University of Hong Kong 83 Tat Chee Ave, Kowloon Tong Hong Kong SAR 999077 P. R. China

Quzhou Institute for Innovation in Resource Chemical Engineering Quzhou 324000 P. R. China

Beijing Area Major Laboratory of Peptide and Small Molecular Drugs Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China Beijing Laboratory of Biomedical Materials Laboratory for Clinical Medicine Beijing Laboratory of Oral Health Capital Medical University Beijing 100069 P. R. China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities

References (62)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1016/j.nantod.2020.10100410.1016/j.nantod.2020.101004 ↗
3. 10.1038/s41568-020-00300-610.1038/s41568-020-00300-6 ↗
4. 10.1038/nrc372610.1038/nrc3726 ↗
5. 10.1016/j.ccr.2022.21449510.1016/j.ccr.2022.214495 ↗
6. 10.1016/j.cej.2020.12487410.1016/j.cej.2020.124874 ↗
7. 10.1016/j.smaim.2022.09.00410.1016/j.smaim.2022.09.004 ↗
8. 10.1016/j.jconrel.2022.04.04710.1016/j.jconrel.2022.04.047 ↗
9. 10.1038/s41467-020-16191-y10.1038/s41467-020-16191-y ↗
10. 10.1016/j.apsb.2021.11.00610.1016/j.apsb.2021.11.006 ↗
11. 10.1038/nchembio.173510.1038/nchembio.1735 ↗
12. 10.1074/jbc.M112.37572510.1074/jbc.M112.375725 ↗
13. 10.1016/j.immuni.2020.03.00110.1016/j.immuni.2020.03.001 ↗
14. 10.1158/1078-0432.CCR-18-122610.1158/1078-0432.CCR-18-1226 ↗
15. 10.2147/IJN.S25554610.2147/IJN.S255546 ↗
16. 10.2147/IJN.S31921010.2147/IJN.S319210 ↗
17. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
18. 10.1039/D2CS00673A10.1039/D2CS00673A ↗
19. 10.1016/j.cej.2022.13862110.1016/j.cej.2022.138621 ↗
20. 10.1038/s41557-020-0448-x10.1038/s41557-020-0448-x ↗
21. 10.1002/smm2.124310.1002/smm2.1243 ↗
22. 10.1021/acsnano.3c0226510.1021/acsnano.3c02265 ↗
23. 10.1021/jacs.3c0947310.1021/jacs.3c09473 ↗
24. 10.1016/j.chempr.2023.06.01110.1016/j.chempr.2023.06.011 ↗
25. 10.1016/j.scib.2023.12.03610.1016/j.scib.2023.12.036 ↗
26. 10.1021/jacs.3c1438710.1021/jacs.3c14387 ↗
27. 10.1002/anie.20211223610.1002/anie.202112236 ↗
28. 10.1016/j.cej.2023.14345710.1016/j.cej.2023.143457 ↗
29. 10.1021/jacs.0c0212910.1021/jacs.0c02129 ↗
30. 10.1002/smm2.109910.1002/smm2.1099 ↗
31. 10.3866/PKU.WHXB20221203910.3866/PKU.WHXB202212039 ↗
32. 10.1016/j.cclet.2023.10814010.1016/j.cclet.2023.108140 ↗
33. 10.1016/j.ccr.2023.21535010.1016/j.ccr.2023.215350 ↗
34. Wu J. · Adv. Mater. · 2023 · 35
35. 10.1038/s41467-023-40826-510.1038/s41467-023-40826-5 ↗
36. 10.1002/anie.20200838610.1002/anie.202008386 ↗
37. 10.1039/D2CS00236A10.1039/D2CS00236A ↗
38. 10.1002/adma.20221120510.1002/adma.202211205 ↗
39. 10.1002/adma.20170437610.1002/adma.201704376 ↗
40. 10.1002/advs.20200027210.1002/advs.202000272 ↗
41. 10.1021/acsnano.1c0046110.1021/acsnano.1c00461 ↗
42. 10.1002/adma.20170738910.1002/adma.201707389 ↗
43. 10.1002/adma.20220969210.1002/adma.202209692 ↗
44. 10.1038/s41467-018-05223-310.1038/s41467-018-05223-3 ↗
45. 10.1038/s41467-022-31106-910.1038/s41467-022-31106-9 ↗
46. 10.1021/jacs.8b0865810.1021/jacs.8b08658 ↗
47. 10.1002/anie.20191081510.1002/anie.201910815 ↗
48. 10.1016/j.cej.2023.14373110.1016/j.cej.2023.143731 ↗
49. 10.1016/j.cej.2022.13723710.1016/j.cej.2022.137237 ↗
50. 10.1016/j.cej.2023.14402810.1016/j.cej.2023.144028 ↗
51. 10.1038/s41467-019-11269-810.1038/s41467-019-11269-8 ↗
52. 10.1136/jitc-2020-00192610.1136/jitc-2020-001926 ↗
53. 10.1021/acsnano.9b0721210.1021/acsnano.9b07212 ↗
54. 10.1146/annurev-immunol-032712-10000810.1146/annurev-immunol-032712-100008 ↗
55. 10.1038/nrc338010.1038/nrc3380 ↗
56. 10.1038/s41419-020-03221-210.1038/s41419-020-03221-2 ↗
57. 10.1002/advs.20220291410.1002/advs.202202914 ↗
58. 10.3390/biomedicines1002043110.3390/biomedicines10020431 ↗
59. 10.1136/annrheumdis-2013-20483710.1136/annrheumdis-2013-204837 ↗
60. 10.1021/acsami.0c1884110.1021/acsami.0c18841 ↗
61. 10.1038/ni.270310.1038/ni.2703 ↗
62. 10.1002/advs.20220369910.1002/advs.202203699 ↗